Abadie, Bryan
Ali, Adel Hajj
Martyn, Trejeeve
Higgins, Andrew
Krishnaswamy, Amar
Reed, Grant
Puri, Rishi
Yun, James
Cremer, Paul
Hanna, Mazen
Tang, W. H. Wilson
Kapadia, Samir
Jaber, Wael http://orcid.org/0000-0001-5642-2112
Article History
Received: 25 May 2023
Accepted: 29 July 2023
First Online: 22 August 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Consent was waived in the setting of minimal risk, as approved by the Cleveland Clinic Institutional Review Board.
: Dr. Martyn receives research support from Ionis Therapeutics related to amyloidosis research, is an advisor to Recora health, and receives research support from Novartis. Dr. Hanna serves on the advisory boards of Alnylam Pharmaceuticals Inc., Eidos, Ionis Therapeutics, and Pfizer Inc. Drs. Jaber and Cremer have institutional coreLab contracts with Edwards Life Sciences, BMS, and Boston Scientific. The remaining authors have no relevant disclosures.